Seventure Partners
Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies.
Business Model:
Revenue: $10M
Employees: 11-50
Rankings
Detailed Seventure Partners Information
Geographic Data
Address: 5-7 rue de Monttessuy
City: Paris
State: île-de-france
Zip: 75340
Country: FR
Financial Info
Stage:
Raised Last:
$0
Raised Total:$812M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
7,013,269Website Global Rank
651Website Monthly Traffic
Twitter Followers
Description
Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion. Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations. Seventure&s;s goal is to identify and support the development of tomorrow&s;s European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2008 | SquareClock | Venture Round | 1.3M |
| 5/2018 | Indexima | Seed Round | 2.4M |
| 11/2005 | Fluxome | Venture Round | 0 |
| 1/2014 | Lecturio | Series A | 4.1M |
| 9/2016 | IDnow | Series A | - |
| 12/2018 | Vedanta Biosciences | Series C | 0 |
| 1/2018 | ENTEROME | Debt Financing | - |
| 3/2015 | Balyo | Series A | 0 |
| 4/2018 | A-Mansia Biotech | Series A | 15.8M |
| 5/2014 | ENTEROME | Series B | 15.3M |
| 4/2016 | ENTEROME | Series C | 16.4M |
| 7/2020 | Clim8 | Series A | 0 |
| 8/2017 | Intento Design | Series B | 1.8M |
| 1/2005 | VoluBill | Series C | 0 |
| 6/2019 | String Bio | Venture Round | - |
| 7/2018 | Izicap | Series A | 10.5M |
| 4/2016 | TargEDys | Series A | 6.5M |
| 4/2017 | TargEDys | Series A | 3.7M |
| 12/2011 | Streamdata.io | Series A | 5.3M |
| 8/2021 | Proteon Therapeutics | Post-IPO Equity | 0 |
| 7/2015 | Eligo Bioscience | Seed Round | 2.9M |
| 9/2018 | Launchmetrics | Equity | 50M |
| 1/2008 | Mauna Kea Technologies | Series B | 30M |
| 1/2010 | Tradoria | Series B | 2.9M |
| 9/2018 | Veact | Series B | - |
| 10/2009 | Plinga | Venture Round | - |
| 7/2012 | Domain Therapeutics | Venture Round | 2.5M |
| 10/2022 | BAOUW / Outdoor Organic Nutrition | Seed Round | 2M |
| 9/2008 | Codasystem | Venture Round | 4.4M |
| 2/2002 | Tak Imaging | Series B | 9.5M |
| 6/2017 | DayTwo | Series A | 12M |
| 7/2020 | Citryll | Series B | 0 |
| 12/2001 | Genome Express | Series B | 0 |
| 4/2021 | Expensya | Series B | 0 |
| 11/2014 | Humedics | Series C | 7.8M |
| 12/2018 | Presto Engineering | Venture Round | - |
| 11/2012 | TxCell | Series C | 16.1M |
| 4/2017 | Pitchy | Series A | 7M |
| 10/2012 | Biophytis | Series B | 0 |
| 3/2017 | Botfuel | Seed Round | 1.3M |
| 2/2016 | MilliDrop | Seed Round | 1.1M |
| 5/2019 | Domain Therapeutics | Venture Round | 3.9M |
| 1/2023 | mediarithmics | Venture Round | 7.4M |
| 6/2018 | LiMM Therapeutics | Venture Round | 2.9M |
| 5/2019 | TransferGo | Series B | 0 |
| 4/2022 | Jolimoi | Series A | 7.6M |
| 9/2019 | LNC Therapeutics | Venture Round | 6.8M |
| 12/2013 | Endocontrol | Venture Round | 5.5M |
| 10/2022 | Citalid Cybersecurity | Series A | 0 |
| 1/2010 | Presto Engineering | Venture Round | 2M |
| 4/2012 | LNC Therapeutics | Series B | 4.6M |
| 7/2021 | Otoqi | Series A | 7.1M |
| 5/2022 | Domain Therapeutics | Series A | 0 |
| 2/2022 | Microbiotica | Series B | 0 |
| 2/2022 | Hepster | Convertible Note | 0 |
| 3/2013 | Nexess | Venture Round | 3.3M |
| 10/2020 | Animab | Seed Round | 0 |
| 5/2012 | Netino | Venture Round | 2.5M |
| 5/2020 | Virovet | Series B | 0 |
| 4/2010 | PhosphonicS | Series B | 5.4M |
| 10/2013 | Middle Peak Medical | Series A | 0 |
| 4/2023 | Graphite Innovation &a; Technologies | Series A | 0 |
| 1/2023 | Ervaccine Technologies | Seed Round | 4.7M |
| 9/2010 | Arlettie | Venture Round | 12.2M |
| 7/2017 | Push Doctor | Series B | 26.1M |
| 2/2020 | NovoBind | Series A | - |
| 12/2010 | Acarix | Seed Round | 6M |
| 6/2010 | QuesCom | Venture Round | 0 |
| 2/2013 | Recommerce Group | Venture Round | 9.3M |
| 6/2019 | DayTwo | Series B | 0 |
| 7/2005 | Boonty | Series B | 10M |
| 10/2021 | Axial Biotherapeutics | Series C | 0 |
| 4/2005 | Tak Imaging | Series C | 10M |
| 2/2000 | Tak Imaging | Series A | - |
| 11/2017 | Il Etait Un Fruit | Venture Round | 0 |
| 1/2004 | Tak Imaging | Series C | 16.3M |
| 12/2010 | E-Blink | Venture Round | 8M |
| 4/2012 | E-Blink | Venture Round | 9.3M |
| 9/2008 | Conject | Venture Round | 7.2M |
| 12/2013 | E-Blink | Venture Round | 0 |
| 7/2021 | Ecto | Equity | 7.2M |
| 6/2022 | Ideel | Venture Round | 2.1M |
| 1/2006 | DxO Labs | Series A | 12.8M |
| 11/2010 | Syntaxin | Series C | 29M |
| 5/2010 | Noxxon Pharma | Series D | 40.7M |
| 3/2003 | BoostWorks | Series C | 9M |
| 7/2015 | Mailjet | Series B | 11M |
| 4/2021 | PEP-Therapy | Series A | 0 |
| 1/2015 | Lecturio | Series B | 4.5M |
| 7/2018 | MDoloris Medical Systems | Private Equity Round | 10.5M |
| 9/2007 | Kayentis | Series C | 6.2M |
| 10/2019 | TIBOT Technologies | Seed Round | 3.3M |
| 6/2015 | jobvalley | Series C | 13.6M |
| 2/2016 | Testbirds | Venture Round | 0 |
| 3/2023 | FIRE1 | Venture Round | 0 |
| 5/2010 | Nanobiotix | Series C | 0 |
| 12/2013 | navabi | Series C | 13.5M |
| 10/2020 | Federation Bio | Series A | 50M |
| 6/2020 | Saagie | Series B | 28.1M |
| 2/2021 | MedinCell | Post-IPO Equity | 36.2M |
| 3/2023 | Glopal | Series A | 0 |
| 9/2012 | Mainstay Medical | Series B | 20M |
| 1/2005 | Netasq | Series C | 5.4M |
| 1/2006 | METabolic EXplorer | Series C | 6.1M |
| 11/2000 | METabolic EXplorer | Series A | 1.3M |
| 7/2015 | MaaT Pharma | Seed Round | 1.1M |
| 3/2014 | PrestaShop | Series B | 9.3M |
| 1/2020 | HARDLOOP | Seed Round | 1.6M |
| 1/2011 | Talentsoft | Venture Round | 4M |
| 7/2012 | jobvalley | Series B | 3.7M |
| 10/2021 | Ecto | Series A | 0 |
| 9/2020 | Galecto | Series D | 0 |
| 10/2021 | Abalos Therapeutics | Series A | 0 |
| 2/2021 | Ervaccine Technologies | Seed Round | 3M |
| 6/2021 | SportEasy | Series A | 6M |
| 11/2015 | Intento Design | Venture Round | 986.6k |
| 3/2021 | Foodsmart | Series C | 0 |
| 3/2010 | Alsyon Technologies | Series B | 858k |
| 12/2011 | arGEN-X | Series B | 43.8M |
| 4/2017 | Business Table | Venture Round | - |
| 2/2016 | payleven | Series D | 0 |
| 5/2022 | Tubulis | Series B | 0 |
| 2/2015 | Kayentis | Venture Round | 0 |
| 7/2014 | Mint Solutions | Series A | 6M |
| 8/2017 | MycoTechnology | Series B | 0 |
| 12/2009 | Hubsphere | Series A | 1.4M |
| 4/2016 | Actronika | Seed Round | 1.4M |
| 9/2021 | CattleEye | Seed Round | 0 |
| 3/2015 | Aenitis Technologies | Seed Round | - |
| 3/2021 | Hepster | Series A | 10M |
| 11/2017 | Scipio Bioscience | Seed Round | 1.4M |
| 1/2018 | Siolta Therapeutics | Seed Round | - |
| 4/2013 | CardioSecur | Series A | 3.3M |
| 3/2015 | Augure | Series E | 16.3M |
| 2/2020 | Scipio Bioscience | Series A | 6.5M |
| 4/2007 | Idylis | Series B | 3.4M |
| 6/2020 | ENTEROME | Series E | 51.9M |
| 5/2013 | Advanced Accelerator Applications | Private Equity Round | 6.2M |
| 10/2015 | Veact | Series A | 3M |
| 2/2006 | Numara Software France | Series C | 5.6M |
| 4/2015 | PEP-Therapy | Seed Round | 1.4M |
| 7/2020 | Tubulis | Series A | 12.3M |
| 1/2011 | Impeto Medical | Series B | 6.8M |
| 9/2013 | Streamdata.io | Series B | 2.7M |
| 10/2017 | FeetMe | Seed Round | 2.3M |
| 10/2006 | Ingenico Healthcare/e-ID | Venture Round | 8.3M |
| 12/2018 | Expensya | Venture Round | 4.5M |
| 9/2019 | JobTeaser | Series C | 55.5M |
| 12/2012 | Myobis | Venture Round | 2M |
| 2/2019 | Axial Biotherapeutics | Series B | 25M |
| 7/2017 | Anaeropharma Science | Venture Round | 13.2M |
| 4/2010 | Implanet | Series C | 10.8M |
| 10/2015 | MycoTechnology | Series A | 0 |
| 9/2009 | BiancaMed | Series B | 8.7M |
| 9/2022 | Standing Ovation | Series A | 12M |
| 8/2016 | Mint Solutions | Series B | 5.6M |
| 5/2011 | Tigerlily | Venture Round | 1.3M |
| 3/2016 | MaaT Pharma | Series A | 11.2M |
| 9/2020 | Siolta Therapeutics | Series B | 30M |
| 11/2018 | HomeRez | Venture Round | 6.8M |
| 9/2007 | VoluBill | Series D | 0 |
| 9/2019 | FeetMe | Series A | 10.4M |
| 1/2022 | 77 Foods | Series A | 0 |
| 8/2005 | aveni | Series B | 14.6M |
| 7/2016 | fromAtoB | Series A | 10.5M |
| 4/2023 | Vedanta Biosciences | Series E | 0 |
| 6/2013 | jobvalley | Series B | - |
| 6/2013 | Middle Peak Medical | Series A | 8.5M |
| 1/2018 | FIRE1 | Series C | 49.6M |
| 5/2021 | Cytoki Pharma | Series A | 45M |
| 1/2021 | Opencell Software | Series A | 0 |
| 10/2022 | Clinical Microbiomics | Venture Round | 10M |
| 12/2008 | WebInterpret | Seed Round | 1.4M |
| 1/2021 | Corwave | Series C | 43.2M |
| 10/2018 | Microbiotica | Venture Round | 5.2M |
| 10/2009 | Talentsoft | Seed Round | 2.3M |
| 3/2020 | MOVE ‘N SEE | Venture Round | 4.5M |
| 12/2016 | Keen Eye Technologies | Seed Round | 1.6M |
| 3/2022 | Polaris | Seed Round | 0 |
| 4/2019 | LiMM Therapeutics | Seed Round | 2.3M |
| 9/2017 | LNC Therapeutics | Series C | 7.6M |
| 5/2007 | Arkeia Software | Series B | 3M |
| 2/2019 | BIOMx | Series B | 0 |
| 2/2020 | MaaT Pharma | Series B | 19.8M |
| 1/2015 | MaaT Pharma | Seed Round | 1.2M |
| 9/2022 | Soan | Venture Round | 0 |
| 1/2011 | Airtag | Venture Round | 5.5M |
| 3/2005 | DSO Interactive | Series B | 2.6M |
| 3/2022 | Geovelo | Series A | 4.2M |
| 1/2017 | CryoCapCell | Seed Round | 1.6M |
| 4/2022 | BCD Bioscience | Series A | 0 |
| 5/2005 | Sefas Innovation | Venture Round | 3.8M |
| 5/2020 | BCD Bioscience | Series A | 0 |
| 1/2010 | Endocontrol | Series A | 4.3M |
| 9/2012 | Web Geo Services | Series A | 2.6M |
| 11/2017 | PEP-Therapy | Seed Round | 1.4M |
| 7/2007 | Glowria | Venture Round | 8.3M |
| 11/2013 | fromAtoB | Seed Round | - |
| 9/2020 | LARQ | Series A | 0 |
| 10/2016 | Foodsmart | Series B | 18M |
| 11/2016 | Corwave | Series B | 17.1M |
| 12/2011 | navabi | Seed Round | 2.8M |
| 7/2013 | Global Bioenergies | Post-IPO Equity | 30.2M |
| 2/2017 | Yelloan | Seed Round | 1.9M |
| 9/2021 | CattleEye | Seed Round | 0 |
| 7/2022 | Sentryc | Series A | 0 |
| 1/2020 | HARDLOOP | Series A | 1.6M |
| 7/2021 | Dopavision | Series A | 14.2M |
| 3/2017 | Chronotruck | Venture Round | 3.7M |
| 8/2014 | MinuteBuzz | Venture Round | 1.3M |
| 2/2015 | Open Ocean | Seed Round | 1.8M |
| 1/2011 | ENTEROME | Seed Round | 2M |
| 1/2009 | MLstate | Venture Round | 2.8M |
| 7/2008 | Fluxome | Series B | 0 |
| 1/2017 | Skinjay | Venture Round | 3.7M |
| 2/2017 | ASTON iTrade Finance | Venture Round | 6.5M |
| 11/2007 | Alsyon Technologies | Series A | 3M |
| 4/2009 | Anevia | Series B | 7M |
| 2/2016 | HorseCom | Seed Round | 1.1M |
| 3/2014 | Testbirds | Series A | 2.9M |
| 4/2014 | WebInterpret | Series A | 6.9M |
| 1/2017 | ENTEROME | Series D | 33.4M |
| 9/2010 | EffiCity | Series B | 5.3M |
| 5/2010 | Eodom | Seed Round | 4.4M |
| 3/2012 | ENTEROME | Series A | 0 |
| 1/2006 | AssurOne Group | Venture Round | 5M |
| 1/2020 | Glopal | Seed Round | 4.5M |
| 2/2008 | TxCell | Series B | 15.6M |
| 4/2005 | Idylis | Series A | 2.6M |
| 6/2012 | Santaris Pharma | Venture Round | 12M |
| 6/2012 | ProTip | Series C | 4.7M |
| 7/2017 | machtfit | Series A | 2.5M |
| 5/2018 | IDnow | Series B | - |
| 8/2007 | Retailo | Series A | - |
| 12/2008 | L4 Digital | Private Equity Round | - |
| 6/2009 | Implanet | Series B | 12.6M |
| 6/2014 | jobvalley | Venture Round | - |
| 2/2015 | Webdata Solutions | Series A | 4.5M |
| 1/2021 | wealthpilot | Venture Round | 9.7M |
| 6/2020 | TransferGo | Venture Round | 0 |
| 4/2016 | Cambrooke Therapeutics | Series C | - |
| 5/2017 | BIOMx | Series A | 24M |
| 11/2020 | Dermala | Series A | 4.5M |
| 1/2015 | JobTeaser | Series A | 3.5M |
| 1/2015 | navabi | Series D | 0 |
| 8/2021 | Proteon Pharmaceuticals | Venture Round | 0 |
| 1/2020 | HARDLOOP | Venture Round | 1.6M |
| 6/2020 | MycoTechnology | Series D | 0 |
| 9/2017 | Eligo Bioscience | Series A | 18M |
| 12/2007 | Santaris Pharma | Series C | 30M |
| 1/2022 | HARDLOOP | Venture Round | 0 |
| 10/2018 | Galecto | Series C | 90.2M |
| 7/2022 | Sentryc | Series A | 0 |
| 5/2022 | Domain Therapeutics | Series A | 0 |
| 5/2022 | Tubulis | Series B | 0 |
| 4/2022 | BCD Bioscience | Series A | 0 |
| 3/2022 | Polaris | Seed Round | 0 |
| 2/2022 | Microbiotica | Series B | 0 |
| 2/2022 | Hepster | Convertible Note | 0 |
| 1/2022 | 77 Foods | Series A | 0 |
| 1/2022 | HARDLOOP | Venture Round | 0 |
| 10/2021 | Abalos Therapeutics | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
